英文摘要 |
Liver disease is one of the major problems cause death among Chinese people. Investigation shows that hepatitis B surface antigen (HBsAg) carriers have more coincidence toward the development of hepatocellular carcinoma. Immunization against hepatitis B virus has helped somewhat in preventing chronic infection cases, but still not enough to solve this problem. Right now there are not many drugs available to treat these disease. Therefore, new drugs to eradicate hepatitis B virus in chronic carriers are needed. |